ScripFlagship Pioneering, the biopharma start-up creation firm behind Moderna , is broadening its horizon beyond its base in Cambridge, MA. It unveiled a new alliance with the UK government in London on 2
ScripJason Gardner is just a month into his role as CEO of Ampersand Biomedicines , one of the latest companies to emerge from Flagship Pioneering , but is nevertheless confident it can deliver a “new pa
ScripThe ongoing reckoning among biopharmaceutical companies that are running out of cash and unable to raise new funds – either because of a lack of near-term upcoming milestones or missed milestones – is
ScripAntibody-drug conjugate specialist Seagen Inc. may have concluded a tumultuous period of several months on 10 November, naming veteran industry executive David Epstein as its new CEO to replace int